Advanced therapies for the management of adults with pulmonary arterial hypertension due to congenital heart disease: a systematic review

Pulmonary arterial hypertension (PAH) secondary to congenital heart disease (CHD) is the third most common cause of PAH, and it is becoming increasingly common as improvements in the management of CHD have led to increased life expectancy for these patients. The medical management of PAH due to CHD...

Descripción completa

Detalles Bibliográficos
Autores principales: Varela, Daniel L, Teleb, Mohamed, El-Mallah, Wael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Pulmonary Vascular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761307/
https://www.ncbi.nlm.nih.gov/pubmed/29344382
http://dx.doi.org/10.1136/openhrt-2017-000744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761307/
https://www.ncbi.nlm.nih.gov/pubmed/29344382
http://dx.doi.org/10.1136/openhrt-2017-000744

Ejemplares similares